Michael Gold

Research Interests

Allergy Immunology Paediatrics Public Health and Health Services Surgical and Health Systems Innovation Child and Adolescent Health Immunology and Infection Translational Health Outcomes

Prof Michael Gold

Professor

School of Medicine

College of Health

Professor Michael Gold is an Immunologist Allergist with established international and national profile in the field of vaccine safety and allergic disorders. Professor Gold has over 20 years of trials experience, both as principle investigator on investigator-led randomised trials and as co-investigator. His specific interests have been in the fields of paediatric food allergy and the surveillance of adverse events following immunisation. He has contributed to research which has received >$5 M in funding in the past 5 years. He has over 130 peer-reviewed publications and has contributed as lead academic author to a number of guidelines for the World Health Organisation (WHO). He has had professional involvement as an appointed member of the WHO Global Advisory Committee for Vaccine Safety as well as being an appointed expert to a number of Australian commonwealth vaccine safety advisory bodies. With the COVID-19 pandemic he has a part-time appointment as a vaccine safety consultant to the South East Asian Region of WHO and has contributed specifically to the global response to the investigation and management of COVID-19 vaccine allergy. His allergy-based research has focused on the prevention of food allergy (primarily egg allergy) with more recent contributions to multicentre trials investigating novel ways to treat peanut allergy.

Date Position Institution name
1994 - ongoing Professsor Univesrity of Adelaide
1994 - ongoing Senior Consultant Womens and Childrens Hospital

Date Institution name Country Title
University of Cape Town South Africa MbChB
College of Paediatrics South Africa DCH
University of Cape Town South Africa MD
College of Medicine South Africa FCP
Royal Australasian College of Physicians, Sydney Australia FRACP

Year Citation
2026 Quach, A., King, J., Putty, T., Gold, M., Quinn, P., & Ferrante, A. (2026). Characterisation of a Leaky Splice-Site Mutation Associated with Phenotypic Diversity in Two Unrelated Patients with ARPC1B Deficiency.. J Clin Immunol, 46(1), 14 pages.
DOI Scopus2 WoS1 Europe PMC1
2026 Huang, L., Lloyd, M., Franz, A., Loke, P., O'Sullivan, M., Gold, M., . . . Dalziel, K. (2026). Cost-Effectiveness of Oral Immunotherapy Treatments vs No Treatment for Peanut Allergy in Children. JAMA Network Open, 9(3), e262410-1-e262410-11.
DOI Scopus3 WoS2 Europe PMC1
2026 Deng, L., Barton, B., Choi, P., Clarke, L., Khanlari, S., Maitland-Scott, I., . . . Wood, N. (2026). Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia. Vaccine, 79, 128501-1-128501-12.
DOI Scopus1 WoS1
2026 Nyambayo, P. P. M., Manyevere, R., Chirinda, L., Marekera, S. F., Nyamandi, T., Chaitezvi, R. P., . . . Gold, M. S. (2026). Zimbabwe adverse events following immunisation surveillance system: A descriptive study with COVID-19 vaccine safety updates.. S Afr J Infect Dis, 41(1), 785.
DOI
2026 Loke, P., Wang, X., Rosser, S., Lloyd, M., Ashley, S. E., Lozinsky, A. C., . . . Tang, M. L. K. (2026). Three-Year Post-Treatment Outcomes Following Cessation of Peanut Oral Immunotherapy: Comparisons by Clinical Allergy Status and Treatment Group. Allergy European Journal of Allergy and Clinical Immunology, 6 pages.
DOI
2025 Chacón, G. P., McAlister, S., Totterdell, J., Estcourt, M. J., Marsh, J. A., Jones, M., . . . Richmond, P. C. (2025). Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccines. Journal of Infection, 91(1), 106515-1-106515-10.
DOI
2025 Deng, L., Van Eldik, A., O’Moore, M., Buttery, J., Cheung, A., Cox, N., . . . Wood, N. (2025). Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia. Npj Vaccines, 10(1), 11 pages.
DOI Scopus11 WoS10 Europe PMC7
2025 Rosser, S. A., Lloyd, M., Loke, P., Ashley, S., O'Sullivan, M. D., Quinn, P., . . . Tang, M. L. K. (2025). Sex assigned at birth may modify health-related quality of life in children treated with peanut oral immunotherapy. Pediatric Allergy and Immunology, 36(8), e70177.
DOI WoS1 Europe PMC1
2024 Lloyd, M., Loke, P., Ashley, S., Lozinsky, A. C., Orsini, F., O'Sullivan, M., . . . Tang, M. L. (2024). Interaction between baseline participant factors and treatment effects following peanut oral immunotherapy. Journal of Allergy and Clinical Immunology: In Practice, 12(4), 1019-1028.e2.
DOI Scopus11 WoS9 Europe PMC9
2024 Chacón, G. P., Estcourt, M. J., Totterdell, J., Marsh, J. A., Perrett, K. P., Campbell, D. E., . . . Snelling, T. (2024). Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS Medicine, 21(6), e1004414-1-e1004414-24.
DOI Scopus5 WoS5 Europe PMC3
2024 Loke, P., Wang, X., Lloyd, M., Ashley, S. E., Lozinsky, A. C., Gold, M., . . . Tang, M. L. K. (2024). Two-year post-treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy-003 Long-Term (PPOIT-003LT) study. Allergy: European Journal of Allergy and Clinical Immunology, 79(10), 2759-2774.
DOI Scopus21 WoS17 Europe PMC11
2024 Lai, C. L., Santner-Nanan, B., Maltese, P. J., Ong, C. K. S., Palmer, D. J., Campbell, D. E., . . . Hsu, P. S. (2024). Impaired calcium influx underlies skewed T helper cell differentiation in children with IgE-mediated food allergies. Allergy, 80(2), 1-12.
DOI Scopus1 WoS1 Europe PMC1
2024 Ashley, S. E., Lloyd, M., Loke, P., Orsini, F., Lozinsky, A. C., O'Sullivan, M. D., . . . Tang, M. L. K. (2024). Allergen Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1-10 Years.. Allergy, 80(3), 843-848.
DOI Scopus13 WoS10 Europe PMC7
2023 Gold, M. S., Amarasinghe, A., Greenhawt, M., Kelso, J. M., Kochhar, S., Yu-Hor Thong, B., . . . Law, B. (2023). Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine, 41(15), 2605-2614.
DOI Scopus57 WoS52 Europe PMC48
2023 Hu, A., Lloyd, M., Loke, P., Chebar Lozinsky, A., O'Sullivan, M., Quinn, P., . . . Tang, M. L. (2023). Association of reaction symptoms and eliciting dose with health-related quality of life in children with peanut allergy. The journal of allergy and clinical immunology. In practice, 11(10), 3195-3202.e4.
DOI Scopus2 WoS1
2023 Tran, H. A., Deng, L., Wood, N., Choi, P., Singleton, S., Clarke, L., . . . Chen, V. M. (2023). The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study. The Lancet Regional Health - Western Pacific, 40, 100894.
DOI Scopus6 WoS6 Europe PMC3
2023 Nyambayo, P. P. M., Gold, M. S., Mehta, U. C., Clarke, S., Manyevere, R., Chirinda, L., . . . Nyamandi, T. (2023). Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial. Vaccine, 41(45), 6700-6709.
DOI Scopus4 Europe PMC3
2022 Netting, M. J., Gold, M. S., Quinn, P., Palmer, S., Makrides, M., & Green, T. J. (2022). Does SMS text messaging promote the early introduction of food allergens? a randomised controlled trial. Pediatric Allergy and Immunology, 33(2), e13720-1-e13720-4.
DOI Scopus8 WoS6 Europe PMC7
2022 Collinson, A. C., Moore, L., Cheung, A., Gold, M. S., & Goh, D. W. (2022). Subcutaneous nodules following vaccination.. Journal of paediatrics and child health, 58(3), 388-391.
DOI Scopus1 WoS1 Europe PMC1
2022 Loke, P., Orsini, F., Lozinsky, A. C., Gold, M., O'Sullivan, M. D., Quinn, P., . . . Ponsonby, A. L. (2022). Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial. The Lancet Child and Adolescent Health, 6(3), 171-184.
DOI Scopus126 WoS117 Europe PMC107
2022 Yap, N., Buttery, J., Crawford, N. W., Omer, S., Heininger, U., Alafaci, A., . . . Wood, N. (2022). The impact of Australian childhood vaccination mandates on immunization specialists and their interactions with families. Pediatric Infectious Disease Journal, 41(5), E188-E193.
DOI Scopus3 Europe PMC1
2022 Sherrey, J., Biggs, S., Dorrian, J., Martin, J., Gold, M., Kennedy, D., & Lushington, K. (2022). Allergic disease, sleep problems and psychological distress in children recruited from the general community. Annals of Allergy, Asthma, and Immunology, 129(3), 366-372.
DOI Scopus18 WoS18 Europe PMC12
2022 Gold, M. S., Quinn, P. J., Campbell, D. E., Peake, J., Smart, J., Robinson, M., . . . Heine, R. G. (2022). Effects of an Amino Acid-Based Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety, and Gut Microbiome in Infants with Cow's Milk Protein Allergy. NUTRIENTS, 14(11), 1-19.
DOI Scopus34 WoS27 Europe PMC23
2022 Palmer, D. J., Sullivan, T. R., Campbell, D. E., Nanan, R., Gold, M. S., Hsu, P. S., . . . Makrides, M. (2022). PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks' gestation during pregnancy to 4 months' lactation on infant IgE-mediated egg and peanut allergy outcomes. BMJ Open, 12(6), e056925-1-e056925-8.
DOI Scopus24 WoS22 Europe PMC20
2022 Tunbridge, M., Perkins, G., Lee, M., Salehi, T., Yuson, C., Le, A., . . . Hissaria, P. (2022). COVID vaccination can be completed in subjects with a history of allergic reactions to the vaccines or their components - experience from a specialist clinic in South Australia.. Intern Med J, 52(11), 1884-1890.
DOI Scopus3 WoS2 Europe PMC2
2021 Lai, C. L., Campbell, D. E., Palmer, D. J., Makrides, M., Santner-Nanan, B., Gold, M., . . . Hsu, P. S. (2021). Longitudinal egg-specific regulatory T and B cell development: insights from primary prevention clinical trials examining the timing of egg introduction.. Allergy, 76(5), 1385-1397.
DOI Scopus11 WoS10 Europe PMC8
2021 Gold, M. S., Lincoln, G., Bednarz, J., Braunack-Mayer, A., & Stocks, N. (2021). Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial. Vaccine, 39(2), 237-246.
DOI Scopus9 WoS8 Europe PMC7
2021 Amponsah-Dacosta, E., Muloiwa, R., Wiysonge, C. S., Gold, M., Hussey, G., & Kagina, B. M. (2021). Developing vaccinology expertise for africa: Fifteen years and counting. Pan African Medical Journal, 38, 313.
DOI Scopus4 Europe PMC3
2021 Des Roches, A., Graham, F., Begin, P., Paradis, L., & Gold, M. (2021). Evaluation of Adverse Reactions to Vaccines. Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3584-3597.
DOI Scopus11 WoS9 Europe PMC8
2020 Damiano, J. A., Deng, L., Li, W., Burgess, R., Schneider, A. L., Crawford, N. W., . . . Berkovic, S. F. (2020). SCN1A Variants in vaccine-related febrile seizures: a prospective study. Annals of Neurology, 87(2), 281-288.
DOI Scopus22 Europe PMC22
2020 Jacoby, P., Glover, C., Damon, C., Fathima, P., Pillsbury, A., Durrheim, D., . . . Snelling, T. (2020). Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study. BMJ open, 10(2), e031851.
DOI Scopus8 Europe PMC8
2020 Gold, M. S., MacDonald, N. E., McMurtry, C. M., Balakrishnan, M. R., Heininger, U., Menning, L., . . . Zuber, P. L. F. (2020). Immunization stress-related response – Redefining immunization anxiety-related reaction as an adverse event following immunization. Vaccine, 38(14), 3015-3020.
DOI Scopus71 Europe PMC71
2020 Omari, T., Tobin, J. M., McCall, L., Savage, K., Ferris, L., Hammond, P., . . . Heine, R. G. (2020). Characterization of upper gastrointestinal motility in infants with persistent distress and non-IgE-mediated cow's milk protein allergy. Journal of Pediatric Gastroenterology and Nutrition, 70(4), 489-496.
DOI Scopus23 WoS21 Europe PMC20
2020 Marshall, H. S., Koehler, A. P., Wang, B., A'Houre, M., Gold, M., Quinn, H., . . . Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922.
DOI Scopus17 WoS13 Europe PMC11
2020 Deng, L., Wood, N., Macartney, K., Gold, M., Crawford, N., Buttery, J., . . . Barton, B. (2020). Developmental outcomes following vaccine-proximate febrile seizures in children. Neurology, 95(3), e226-e238.
DOI Scopus8 Europe PMC4
2020 Netting, M. J., Gold, M. S., & Palmer, D. J. (2020). Low allergen content of commercial baby foods. Journal of Paediatrics and Child Health, 56(10), 1613-1617.
DOI Scopus14 WoS11 Europe PMC8
2020 Chebar Lozinsky, A., Loke, P., Orsini, F., O'Sullivan, M., L Prescott, S., Gold, M. S., . . . Lk Tang, M. (2020). Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study). BMJ Open, 10(9), e035871-1-e035871-10.
DOI Scopus20 WoS18 Europe PMC15
2020 Gold, M. S., Lincoln, G., Cashman, P., Braunack-Mayer, A., & Stocks, N. (2020). Efficacy of m-Health for the detection of adverse events following immunization – the stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial. Vaccine, 39(2), 332-342.
DOI Scopus6 WoS5 Europe PMC6
2020 Perez Chacon, G., Estcourt, M. J., Totterdell, J., Campbell, D. E., Perrett, K. P., Marsh, J. A., . . . Snelling, T. L. (2020). OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. BMJ Open, 10(12), e042838-1-e042838-11.
DOI Scopus9 WoS9 Europe PMC7
2020 Boyle, R., Brown, N., Chiang, W. C., Chien, C. M., Gold, M., Hourihane, J., . . . Warner, J. (2020). Retraction: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial (Clin Transl Allergy, (2015), 5, (Supplement 3), P30, 10.1186/2045-7022-5-S3-P30). Clinical and Translational Allergy, 10(1).
DOI Scopus2
2019 Blyth, C. C., Macartney, K. K., McRae, J., Clark, J. E., Marshall, H. S., Buttery, J., . . . Influenza Complications Alert Network (FluCAN) Collaboration. (2019). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: results from the PAEDS-FluCAN Collaboration. Clinical Infectious Diseases, 68(6), 940-948.
DOI Scopus51 WoS54 Europe PMC49
2019 Duszynski, K. M., Pratt, N. L., Lynch, J. W., Berry, J. G., & Gold, M. S. (2019). Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index. Vaccine, 37(2), 280-288.
DOI Scopus3 WoS3 Europe PMC3
2019 Volpi, S., Cicalese, M. P., Tuijnenburg, P., Tool, A. T. J., Cuadrado, E., Abu-Halaweh, M., . . . Kuijpers, T. W. (2019). A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency. Journal of Allergy and Clinical Immunology, 143(6), 2296-2299.
DOI Scopus108 WoS90 Europe PMC91
2019 Deng, L., Gidding, H., Macartney, K., Crawford, N., Buttery, J., Gold, M., . . . Wood, N. (2019). Postvaccination Febrile Seizure Severity and Outcome. Pediatrics, 143(5), 11 pages.
DOI Scopus27 Europe PMC16
2019 Duszynski, K. M., Pratt, N. L., Lynch, J. W., Braunack-Mayer, A., Taylor, L. K., Berry, J. G., . . . Gold, M. S. (2019). Process trumps potential public good: better vaccine safety through linked cross-jurisdictional immunisation data in Australia. Australian and New Zealand Journal of Public Health, 43(5), 496-503.
DOI Scopus11 WoS10 Europe PMC8
2019 Estcourt, M. J., Campbell, D. E., Gold, M. S., Richmond, P., Allen, K. J., Quinn, H. E., . . . Snelling, T. L. (2019). Whole-cell pertussis vaccination and decreased Risk of IgE-mediated food allergy: a nested case-control study. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 2004-2014.
DOI Scopus22 WoS18 Europe PMC19
2018 Estcourt, M. J., Marsh, J. A., Campbell, D. E., Gold, M. S., Allen, K. J., Richmond, P., . . . Snelling, T. L. (2018). Protocol for Pertussis Immunisation and Food Allergy (PIFA): a case-control study of the association between pertussis vaccination in infancy and the risk of IgE-mediated food allergy among Australian children. BMJ Open, 8(1), e020232-1-e020232-8.
DOI Scopus3 WoS3 Europe PMC3
2018 Best, K. P., Sullivan, T. R., Palmer, D. J., Gold, M., Martin, J., Kennedy, D., & Makrides, M. (2018). Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhood - a longitudinal analysis of long-term follow-up of a randomized controlled trial. World Allergy Organization Journal, 11(1), 10-1-10-11.
DOI Scopus42 WoS35 Europe PMC32
2018 Pillsbury, A., Glover, C., Jacoby, P., Quinn, H., Fathima, P., Cashman, P., . . . Macartney, K. (2018). Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open, 8(10), 1-11.
DOI Scopus34 Europe PMC34
2018 Patterson, J., Kagina, B., Gold, M., Hussey, G., & Muloiwa, R. (2018). Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: a systematic review. Vaccine, 36(40), 6007-6016.
DOI Scopus33 Europe PMC23
2018 Ameratunga, R., Gillis, D., Gold, M., Linneberg, A., Hawkes, D., Langguth, D., & Elwood, M. (2018). Reply to Crépeaux et al and Blasco. Journal of Allergy and Clinical Immunology in Practice, 6(2), 708-710.
DOI Scopus3 Europe PMC3
2017 Palmer, D., Sullivan, T., Gold, M., Prescott, S., & Makrides, M. (2017). Randomized controlled trial of early regular egg intake to prevent egg allergy. Journal of Allergy and Clinical Immunology, 139(5), 1600.
DOI Scopus187 WoS151 Europe PMC140
2017 Patterson, J., Kagina, B. M., Gold, M., Hussey, G. D., & Muloiwa, R. (2017). Adverse events following primary and secondary immunisation with whole-cell pertussis: A systematic review protocol. BMJ Open, 7(1), e012945.
DOI Scopus5 Europe PMC4
2017 Palmer, D., Sullivan, T., Gold, M., Prescott, S., & Makrides, M. (2017). Association between family characteristics and the effect of timing of regular egg introduction in infant egg allergy. JAMA Pediatrics, 171(5), 489-490.
DOI Scopus3 WoS3 Europe PMC3
2017 Cashman, P., Macartney, K., Khandaker, G., King, C., Gold, M., & Durrheima, D. (2017). Participant-centred active surveillance of adverse events following immunisation: A narrative review. International Health, 9(3), 164-176.
DOI Scopus38 WoS35 Europe PMC32
2017 Netting, M., Gold, M., Quinn, P., El-Merhibi, A., Penttila, I., & Makrides, M. (2017). Randomised controlled trial of a baked egg intervention in young children allergic to raw egg but not baked egg. World Allergy Organization Journal, 10(1), 22-1-22-9.
DOI Scopus29 WoS27 Europe PMC25
2017 Macartney, K., Gidding, H., Trinh, L., Wang, H., Dey, A., Hull, B., . . . Wood, N. (2017). Evaluation of combination measles-mumps-rubella-varicella vaccine introduction in Australia. JAMA Pediatrics, 171(10), 992-998.
DOI Scopus41 WoS38 Europe PMC32
2017 Ameratunga, R., Gillis, D., Gold, M., Linneberg, A., & Elwood, J. M. (2017). Evidence refuting the existence of autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA). Journal of Allergy and Clinical Immunology: In Practice, 5(6), 1551-1555.e1.
DOI Scopus67 WoS54 Europe PMC46
2017 Mehr, S., Frith, K., Barnes, E., Campbell, D., Allen, K., Barnes, E., . . . Zurynski, Y. (2017). Food protein–induced enterocolitis syndrome in Australia: A population-based study, 2012-2014. Journal of Allergy and Clinical Immunology, 140(5), 1323-1330.
DOI Scopus183 Europe PMC138
2016 Metcalfe, J., D'Vaz, N., Makrides, M., Gold, M., Quinn, P., West, C., . . . Palmer, D. (2016). Elevated IL-5 and IL-13 responses to egg proteins predate the introduction of egg in solid foods in infants with eczema. Clinical and Experimental Allergy, 46(2), 308-316.
DOI Scopus23 WoS21 Europe PMC17
2016 Best, K., Gold, M., Kennedy, D., Martin, J., & Makrides, M. (2016). Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials. American Journal of Clinical Nutrition, 103(1), 128-143.
DOI Scopus155 WoS123 Europe PMC107
2016 Gold, M. S., Balakrishnan, M. R., Amarasinghe, A., & MacDonald, N. E. (2016). An approach to death as an adverse event following immunization. Vaccine, 34(2), 212-217.
DOI Scopus21 Europe PMC20
2016 Best, K. P., Sullivan, T., Palmer, D., Gold, M., Kennedy, D. J., Martin, J., & Makrides, M. (2016). Prenatal fish oil supplementation and allergy: 6-year follow-up of a randomized controlled trial. Pediatrics, 137(6), 1-9.
DOI Scopus61 WoS56 Europe PMC47
2016 Crawford, N., Hodgson, K., Gold, M., Buttery, J., & Wood, N. (2016). Adverse events following HPV immunization in Australia: establishment of a clinical network. Human Vaccines and Immunotherapeutics, 12(10), 2662-2665.
DOI Scopus15 Europe PMC10
2016 Holt, P., Snelling, T., White, O., Sly, P., DeKlerk, N., Carapetis, J., . . . Gold, M. (2016). Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria–Pertussis–Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) – Immunological curiosity or canary in the mine?. Vaccine, 34(35), 4257-4262.
DOI Scopus13 WoS11 Europe PMC12
2016 Zurzolo, G., Koplin, J., Ponsonby, A., McWilliam, V., Dharmage, S., Heine, R., . . . Allen, K. (2016). Consensus of stakeholders on precautionary allergen labelling: a report from the Centre for Food and Allergy Research. Journal of Paediatrics and Child Health, 52(8), 797-801.
DOI Scopus18 WoS18 Europe PMC10
2016 Norman, M., South, C., Quinn, P., Chan, D., Palmer, S., Netting, M., & Gold, M. (2016). Does providing written dietary advice improve the ingestion of non-allergic nuts in children with existing nut allergies? - A randomized controlled trial. Clinical and Experimental Allergy, 46(5), 741-748.
DOI Scopus10 WoS10 Europe PMC10
2016 Dreskin, S., Halsey, N., Kelso, J., Wood, R., Hummell, D., Edwards, K., . . . Rosenwasser, L. (2016). International Consensus (ICON): allergic reactions to vaccines. World Allergy Organization Journal, 9(1), 32.
DOI Scopus177 WoS155 Europe PMC124
2016 Camfferman, D., Short, M., Kennedy, J., Gold, M., Kohler, M., & Lushington, K. (2016). Thermoregulation, scratch, itch and sleep deficits in children with eczema. Sleep Medicine, 25, 145-150.
DOI Scopus20 WoS17 Europe PMC15
2016 Boyle, R., Tang, M. -K., Chiang, W., Chua, M., Ismail, I., Nauta, A., . . . Warner, J. (2016). Prebiotic-supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high-risk infants: a randomized controlled trial. Allergy, 71(5), 701-710.
DOI Scopus95 Europe PMC66
2015 Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., . . . Wood, N. (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417.
DOI Scopus29 WoS24 Europe PMC19
2015 Netting, M., Donato, A., Makrides, M., Gold, M., Quinn, P., & Penttila, I. (2015). Allergenicity of pasteurized whole raw Hen’s egg compared with fresh whole raw Hen’s egg. Pediatric Allergy and Immunology, 26(3), 234-238.
DOI Scopus17 WoS16 Europe PMC10
2015 Pillsbury, A., Cashman, P., Leeb, A., Regan, A., Westphal, D., Snelling, T., . . . Prince, K. (2015). Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015. Eurosurveillance, 20(43), 5 pages.
DOI Europe PMC29
2014 Parrella, A., Gold, M., Braunack-Mayer, A., Baghurst, P., & Marshall, H. (2014). Consumer reporting of adverse events following immunization (AEFI): Identifying predictors of reporting an AEFI. Human Vaccines & Immunotherapeutics, 10(3), 747-754.
DOI Scopus16 WoS14 Europe PMC15
2014 Wood, N., Blyth, C., Willis, G., Richmond, P., Gold, M., Buttery, J., . . . Macartney, K. (2014). The safety of seasonal influenza vaccines in Australian children in 2013. Medical Journal of Australia, 201(10), 596-600.
DOI Scopus12 Europe PMC7
2014 Khandaker, G., Zurynski, Y., Ridley, G., Buttery, J., Marshall, H., Richmond, P., . . . Elliott, E. (2014). Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza and Other Respiratory Viruses, 8(6), 636-645.
DOI Scopus26 WoS17 Europe PMC24
2014 Harvey, G., Gold, M., & Warren, L. (2014). Allergy testing in paediatric atopic dermatitis. Medicine Today, 15(5), 42-46.
2013 Palmer, D., Sullivan, T., Gold, M., Prescott, S., Heddle, R., Gibson, R., & Makrides, M. (2013). Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy, 68(11), 1370-1376.
DOI Scopus84 WoS72 Europe PMC69
2013 Camfferman, D., Kennedy, J., Gold, M., Simpson, C., & Lushington, K. (2013). Sleep and neurocognitive functioning in children with eczema. International Journal of Psychophysiology, 89(2), 265-272.
DOI Scopus66 WoS56 Europe PMC53
2013 Parrella, A., Braunack-Mayer, A., Gold, M., Marshall, H., & Baghurst, P. (2013). Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Services Research, 13(313), 1-12.
DOI Scopus46 WoS44 Europe PMC35
2013 Palmer, D., Metcalfe, J., Makrides, M., Gold, M., Quinn, P., West, C., . . . Prescott, S. (2013). Early regular egg exposure in infants with eczema: a randomized controlled trial. Journal of Allergy and Clinical Immunology, 132(2), 387-392.
DOI Scopus308 WoS267 Europe PMC226
2013 Netting, M., Makrides, M., Gold, M., Quinn, P., & Penttila, I. (2013). Heated allergens and induction of tolerance in food allergic children. Nutrients, 5(6), 2028-2046.
DOI Scopus13 WoS14 Europe PMC9
2013 Berry, J., Ryan, P., Duszynski, K., Braunack-Mayer, A., Carlson, J., Xafis, V., & Gold, M. (2013). Parent perspectives on consent for the linkage of data to evaluate vaccine safety: A randomised trial of opt-in and opt-out consent. Clinical Trials, 10(3), 483-494.
DOI Scopus14 WoS13 Europe PMC11
2013 Marshall, H., McIntyre, P., Richmond, P., Buttery, J., Royle, J., Gold, M., . . . Booy, R. (2013). Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatric Infectious Disease Journal, 32(5), 530-537.
DOI Scopus38 WoS33 Europe PMC29
2013 Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., & Baghurst, P. (2013). Parental perspectives of vaccine safety and experience of adverse events following immunisation. Vaccine, 31(16), 2067-2074.
DOI Scopus42 WoS38 Europe PMC34
2013 Newland, K., Warren, L., & Gold, M. (2013). Food allergy testing in infantile eczema: a clinical approach and algorithm. Australasian Journal of Dermatology, 54(2), 79-84.
DOI Scopus9 WoS8 Europe PMC5
2013 Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., . . . Liu, S. (2013). International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458.
DOI Scopus95 WoS85 Europe PMC80
2013 Zurynski, Y., McIntyre, P., Booy, R., Elliott, E., & PAEDS Investigators Group.. (2013). Paediatric active enhanced disease surveillance: a new surveillance system for Australia. Journal of Paediatrics and Child Health, 49(7), 588-594.
DOI
2012 Empson, M., Tang, M., Pearce, L., Rozen, L., Gold, M., Katelaris, C., . . . Maher, D. (2012). Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency. Journal of Clinical Immunology, 32(5), 897-906.
DOI Scopus6 WoS5 Europe PMC6
2012 Khandaker, G., Zurynski, Y., Buttery, J., Marshall, H., Richmond, P., Dale, R., . . . Booy, R. (2012). Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology, 79(14), 1474-1481.
DOI Scopus76 WoS65 Europe PMC67
2012 Khandaker, G., Rashid, H., Zurynski, Y., Richmond, P., Buttery, J., Marshall, H., . . . Booy, R. (2012). Nosocomial vs community-acquired pandemic influenza A (H1N1) 2009: a nested case-control study. Journal of Hospital Infection, 82(2), 94-100.
DOI Scopus8 WoS8 Europe PMC9
2012 Gold, M. (2012). A clinical approach to the investigation of suspected vaccine anaphylaxis. Current Allergy & Clinical Immunology, 25(2), 68-70.
Scopus5 WoS4
2012 Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., Watson, M., & Baghurst, P. (2012). Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Human Vaccines & Immunotherapeutics, 8(5), 662-667.
DOI Scopus21 WoS18 Europe PMC17
2012 Berry, J., Ryan, P., Gold, M., Braunack-Mayer, A., & Duszynski, K. (2012). A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage. Journal of Medical Ethics, 38(10), 619-625.
DOI Scopus22 WoS23 Europe PMC21
2012 Mullins, R., & Gold, M. (2012). Influenza vaccination of the egg-allergic individual: 2012 update. Medical Journal of Australia, 196(11), 682.
DOI Scopus1
2012 Berry, J., Gold, M., Ryan, P., Duszynski, K., & Braunack-Mayer, A. (2012). Public perspectives on consent for the linkage of data to evaluate vaccine safety. Vaccine, 30(28), 4167-4174.
DOI Scopus11 WoS10 Europe PMC7
2012 Boog, B., Quach, A., Costabile, M., Smart, J., Quinn, P., Singh, H., . . . Ferrante, A. (2012). Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91phox resulting in the rare X91⁺ variant of chronic granulomatous disease. Human Mutation, 33(3), 471-475.
DOI Scopus7 WoS8 Europe PMC7
2012 Palmer, D., Sullivan, T., Gold, M., Prescott, S., Heddle, R., Gibson, R., & Makrides, M. (2012). Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. British Medical Journal, 344(7845), E184-1-E184-11.
DOI Scopus209 WoS177 Europe PMC145
2011 Xafis, V., Thomson, C., Braunack-Mayer, A., Duszynski, K., & Gold, M. (2011). Legal impediments to data linkage. Journal of Law and Medicine, 19(2), 300-315.
Scopus3 Europe PMC2
2011 Clarke, M., Davidson, G., Gold, M., & Marshall, H. (2011). Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine, 29(29-30), 4663-4667.
DOI Scopus55 WoS51 Europe PMC43
2011 Quinn, P., Gold, M., Royle, J., Buttery, J., Richmond, P., McIntyre, P., . . . Marshall, H. (2011). Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine, 29(25), 4230-4237.
DOI Scopus19 WoS20 Europe PMC13
2011 Khandaker, G., Marshall, H., Peadon, E., Zurynski, Y., Burgner, D., Buttery, J., . . . Booy, R. (2011). Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Archives of Disease in Childhood, 96(5), 453-456.
DOI Scopus52 WoS39 Europe PMC35
2011 Berry, J., Ryan, P., Braunack-Mayer, A., Duszynski, K., Xafis, V., & Gold, M. (2011). A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage: study protocol. Trials, 12(1), 1-10.
DOI Scopus12 WoS14 Europe PMC17
2011 Mullins, R. J., & Gold, M. S. (2011). Influenza vaccination of the egg-allergic individual. Medical Journal of Australia, 195(1), 52.
DOI Scopus2 WoS2 Europe PMC1
2010 Camfferman, D., Kennedy, J., Gold, M., Martin, A., Winwood, P., & Lushington, K. (2010). Eczema, sleep, and behavior in children. The Journal of Clinical Sleep Medicine, 6(6), 581-588.
DOI Scopus78 WoS71 Europe PMC35
2010 Zanoni, G., Gottin, L., Boner, A., Piacentini, G., Peroni, D., & Gold, M. (2010). Case discussion of an immediate serious reaction to hexavalent vaccine mistaken for anaphylaxis. British Journal of Clinical Pharmacology, 70(6), 916-917.
DOI Scopus5 Europe PMC1
2010 Gold, M., Buttery, J., & McIntyre, P. (2010). Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance. Sexual Health, 7(3), 320-324.
DOI Scopus17 WoS15 Europe PMC14
2010 Gold, M., Gidudu, J., Erlewyn-Lajeunesse, M., & Law, B. (2010). Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Vaccine, 28(28), 4487-4498.
DOI Scopus39 WoS36 Europe PMC29
2010 Gold, M., Dugdale, S., Woodman, R., & Mc Caul, K. (2010). Use of the Australian Childhood Immunisation Register for vaccine safety data linkage. Vaccine, 28(26), 4308-4311.
DOI Scopus33 Europe PMC20
2010 Camfferman, D., Kennedy, J., Gold, M., Martin, A., & Lushington, K. (2010). Eczema and sleep and its relationship to daytime functioning in children. Sleep Medicine Reviews, 14(6), 359-369.
DOI Scopus136 WoS116 Europe PMC105
2010 Gold, M. S., Effler, P., Kelly, H., Richmond, P. C., & Buttery, J. P. (2010). Febrile convulsions after 2010 seasonal trivalent influenza vaccine: Implications for vaccine safety surveillance in Australia. Medical Journal of Australia, 193(9), 492-493.
DOI Scopus38 WoS37 Europe PMC24
2010 Mullins, R. J., Kemp, A., & Gold, M. (2010). Influenza vaccination of the egg-allergic individual. Medical Journal of Australia, 193(5), 254-255.
DOI Scopus7 Europe PMC2
2010 Mahajan, D., Roomiani, I., Gold, M. S., Lawrence, G. L., McIntyre, P. B., & Menzies, R. I. (2010). Annual report: surveillance of adverse events following immunisation in Australia, 2009.. Communicable Diseases Intelligence Quarterly Report, 34(3), 259-276.
DOI Scopus31 Europe PMC22
2009 Black, S., Eskola, J., Siegrist, C., Halsey, N., MacDonald, N., Law, B., . . . Vellozi, C. (2009). Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet, 374(9707), 2115-2122.
DOI Scopus226 Europe PMC185
2009 Bonhoeffer, J., Bentsi-Enchill, A., Chen, R., Fisher, M., Gold, M., Hartman, K., . . . Wise, R. (2009). Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine, 27(16), 2289-2297.
DOI Scopus36 WoS30 Europe PMC27
2009 Bonhoeffer, J., Bentsi-Enchill, A., Chen, R., Fisher, M., Gold, M., Hartman, K., . . . Wise, R. (2009). Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine, 27(16), 2282-2288.
DOI Scopus50 WoS46 Europe PMC36
2009 Menzies, R., Mahajan, D., Gold, M. S., Roomianai, I., McIntyre, P., & Lawrence, G. (2009). Annual report: surveillance of adverse events following immunisation in Australia, 2008. Communicable Diseases Intelligence Quarterly Report, 33(4), 365-381.
DOI Scopus17 Europe PMC10
2009 Brotherton, J., Kemp, A., Burgess, M., & Gold, M. (2009). HPV vaccination reactions [Letter]. Australian Family Physician, 38(5), 381.
2009 Brotherton, J., Kemp, A., Burgess, M., & Gold, M. (2009). HPV vaccination reactions. Australian Family Physician, 38(5), 281.
2009 de Benedictis, F. M., Franceschini, F., Hill, D., Naspitz, C., Simons, F. E. R., Wahn, U., . . . Vogel, M. (2009). The allergic sensitization in infants with atopic eczema from different countries. Allergy European Journal of Allergy and Clinical Immunology, 64(2), 295-303.
DOI Scopus102 Europe PMC68
2008 Kang, L., Crawford, N., Tang, M., Buttery, J., Royle, J., Gold, M., . . . Choo, S. (2008). Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study. British Medical Journal, 337(a2642), 1-5.
DOI Scopus50 WoS39 Europe PMC28
2008 Brotherton, J., & Gold, M. (2008). Monitoring vaccine safety: a critical component of every immunisation program. Medical Journal of Australia, 189(5), 243-244.
DOI Scopus5 WoS8 Europe PMC3
2008 Brotherton, J., Gold, M., Kemp, A., McIntyre, P., Burgess, M., & Campbell-Lloyd, S. (2008). Anaphylaxis following quadrivalent human papillomavirus vaccination. Canadian Medical Association Journal, 179(6), 525-533.
DOI Scopus106 WoS89 Europe PMC64
2008 Palmer, D., Gold, M., & Makrides, M. (2008). Effect of maternal egg consumption on breast milk ovalbumin concentration. Clinical and Experimental Allergy, 38(7), 1186-1191.
DOI Scopus67 WoS55 Europe PMC41
2008 Lawrence, G., Gold, M. S., Hill, R., Deeks, S., Glasswell, A., & McIntyre, P. B. (2008). Annual report: surveillance of adverse events following immunisation in Australia, 2007. Communicable Diseases Intelligence Quarterly Report, 32(4), 371-387.
DOI Scopus23 Europe PMC14
2008 Grüber, C., Warner, J., Hill, D., Bauchau, V., Warner, J. O., Naspitz, C. K., . . . Abeck, D. (2008). Early atopic disease and early childhood immunization - Is there a link?. Allergy European Journal of Allergy and Clinical Immunology, 63(11), 1464-1472.
DOI Scopus54 WoS43 Europe PMC32
2008 Hill, D. J., Hosking, C. S., de Benedictis, F. M., Oranje, A. P., Diepgen, T. L., Bauchau, V., & EPAAC Study Group. (2008). Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clinical & Experimental Allergy, 38(1), 161-168.
DOI Scopus206 WoS171 Europe PMC122
2007 Lawrence, G., Aratchige, P., Boyd, I., McIntyre, P., & Gold, M. (2007). Annual report on surveillance of adverse events following immunisation in Australia 2006. Communicable Disease Intelligence, 31(3), 269-282.
DOI Scopus13 Europe PMC8
2007 Ruggeberg, J., Gold, M., Bayas, J., Blum, M., Bonhoeffer, J., Friedlander, S., . . . Simpson, N. (2007). Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 25(31), 5675-5684.
DOI Scopus342 Europe PMC291
2006 Gold, M. (2006). Prevention and Management of Anaphylaxis in Schools - The Challenge of Policy and Practice. Allergy and Clinical Immunology International, 18(1), 11-14.
DOI Scopus3
2006 Peadon, E., Burgner, D., Nissen, M., Buttery, J., Zurynski, Y., Elliott, E., . . . Booy, R. (2006). Case for varicella surveillance in Australia. Journal of Paediatrics and Child Health, 42(11), 663-664.
DOI Scopus7 WoS2 Europe PMC7
2006 Hofman, T., Cranswick, N., Kuna, P., Boznanski, A., Latos, T., Gold, M., . . . Szalai, Z. (2006). Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Archives of Disease in Childhood, 91(11), 905-910.
DOI Scopus33 WoS29 Europe PMC24
2006 Marshall, H., Gold, M., Gent, R., Quinn, P., Piotto, L., Clarke, M., & Roberton, D. (2006). Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children. Pediatrics, 118(4), 1501-1509.
DOI Scopus22 WoS20 Europe PMC17
2006 Brown, S., Mullins, R., & Gold, M. (2006). Anaphylaxis: diagnosis and management. Medical Journal of Australia, 185(5), 283-289.
DOI Scopus134 Europe PMC34
2006 Brown, S. G. A., Mullins, R. J., & Gold, M. S. (2006). Allergy - 2. Anaphylaxis: diagnosis and management. MEDICAL JOURNAL OF AUSTRALIA, 185(5), 283-289.
DOI WoS110
2006 Brown, S. G. A., Mullins, R. J., & Gold, M. S. (2006). Erratum: "2. Anaphylaxis: Diagnosis and management" (Medical Journal of Australia (2006) vol. 185 ( 283-289)). Medical Journal of Australia, 185(7), 400.
DOI Scopus3
2005 Palmer, D., Gold, M., & Makrides, M. (2005). Effect of cooked and raw egg consumption on ovalbumin content of human milk: a randomized, double-blind, cross-over trial. Clinical and Experimental Allergy, 35(2), 173-178.
DOI Scopus97 WoS84 Europe PMC68
2005 Gold, M. S., & Kemp, A. S. (2005). 6. Atopic disease in childhood. Medical Journal of Australia, 182(6), 298-304.
DOI Scopus62 Europe PMC43
2004 Baumgart, K., Brown, S., Gold, M., Kemp, A., Loblay, R., Loh, R., . . . Ziegler, J. (2004). ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres. Journal of Paediatrics and Child Health, 40(12), 669-671.
DOI Scopus34 WoS36 Europe PMC24
2004 Morwood, K., Bourne, H., Philpot, R., Gold, M., Gillis, D., & Benson, E. (2004). Phenotypic variability: Clinical presentation between the 6th year and the 60th year in a family with X-linked agammaglobulinemia. Journal of Allergy and Clinical Immunology, 113(4), 783-785.
DOI Scopus20 Europe PMC15
2004 Smith, W., Thompson, D., Kummerow, M., Quinn, P., & Gold, M. (2004). A2 milk is allergenic. Medical Journal of Australia, 181(10), 574.
DOI
2004 Palmer, D., Gold, M., & Makrides, M. (2004). Treatment and prevention of food allergies in breastfed infants: practice and evidence. Nutrition & Dietetics, 61(2), 76-81.
2004 Roberton, D., Marshall, H., Dinan, L., Boros, C., & Gold, M. (2004). Developmental immunology and vaccines: immune responses to vaccines in premature infants. Expert Review of Vaccines, 3(4), 343-347.
DOI Scopus7 Europe PMC7
2004 Bonhoeffer, J., Gold, M., Heijbel, H., Vermeer, P., Blumberg, D., Braun, M., . . . Nokleby, H. (2004). Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine, 22(5-6), 563-568.
DOI Scopus24 Europe PMC18
2004 Bonhoeffer, J., Menkes, J., Gold, M., de Souza-Brito, G., Fisher, M., Halsey, N., & Vermeer, P. (2004). Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine, 22(5-6), 557-562.
DOI Scopus91 Europe PMC73
2003 Gold, M. (2003). EpiPen epidemic or good clinical practice?. Journal of Paediatrics and Child Health, 39(5), 376-377.
DOI Scopus14 WoS15 Europe PMC12
2003 Gold, M., Noonan, S., Osbourn, M., Precepa, S., & Kempe, A. (2003). Local reactions after the fourth-dose of acellular pertussis vaccine in South Australia. Medical Journal of Australia, 179(4), 191-194.
DOI Scopus30 Europe PMC19
2003 Goldwater, P., Braunack-Mayer, A., Power, R., Henning, P., Gold, M., Donald, T., . . . Finlay, C. (2003). Childhood tetanus in Australia: ethical issues for a should-be-forgotten preventable disease. Medical Journal of Australia, 178(4), 175-177.
DOI Scopus4 WoS4 Europe PMC3
2003 Gold, M. S. (2003). Vaccination strategy for children with previous vaccine-associated adverse reactions. Vaccines Children and Practice, 6(1), 5-8.
Scopus1
2003 Palmer, D. J., Gold, M. S., & Makrides, M. (2003). The effect of egg ingestion on ovalbumin concentration in human milk.. Asia Pacific Journal of Clinical Nutrition, 12(Suppl), S46.
2002 Gold, M. (2002). Hypotonic-Hyporesponsive Episodes Following Pertussis Vaccination: A Cause for Concern?. Drug Safety, 25(2), 85-90.
DOI Scopus19 Europe PMC11
2002 Turnbull, F., McIntyre, P., Achat, H., Wang, H., Stapledon, R., Gold, M., & Burgess, M. (2002). National study of adverse reactions after vaccination with bacille Calmette-Guérin. Clinical Infectious Diseases, 34(4), 447-453.
DOI Scopus100 WoS71 Europe PMC55
2001 Boros, C., Hanlon, M., Gold, M., & Roberton, D. (2001). Storage at -3oC for 24 h alters the immunogenicity of pertussis vaccines. Vaccine, 19(25-26), 3537-3542.
DOI Scopus37 WoS36 Europe PMC30
2000 Gold, M. (2000). The prevention, diagnosis and management of allergic disease in childhood. Current Paediatrics, 10(3), 137-144.
DOI
2000 Gold, M., Goodwin, H., Botham, S., Burgess, M., Nash, M., & Kempe, A. (2000). Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Archives of Disease in Childhood, 83(2), 128-131.
DOI Scopus68 Europe PMC42
2000 Boros, C., Kay, D., & Gold, M. (2000). Parent reported allergy and anaphylaxis in 4173 South Australian children. Journal of Paediatrics and Child Health, 36(1), 36-40.
DOI Scopus85 WoS73 Europe PMC47
2000 Gold, M., & Sainsbury, R. (2000). First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). Journal of Allergy and Clinical Immunology, 106(1), 171-176.
DOI Scopus224 WoS191 Europe PMC140
2000 D'Souza, R. M., Campbell-Lloyd, S., Isaacs, D., Gold, M., Burgess, M., Turnbull, F., & O'Brien, E. (2000). Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.. Communicable Diseases Intelligence, 24(2), 27-33.
DOI Scopus41 Europe PMC22
1999 Gold, M., Martin, L., Nayda, C., & Kempe, A. (1999). Electronic temperature monitoring and feedback to correct adverse vaccine storage in general practice. Medical Journal of Australia, 171(2), 83-84.
DOI Scopus21 Europe PMC12
1999 Goodwin, H., Nash, M., Gold, M., Heath, T., & Burgess, M. (1999). Vaccination of children following a previous hypotonic-hyporesponsive episode. Journal of Paediatrics and Child Health, 35(6), 549-552.
DOI Scopus36 Europe PMC20
1999 Gold, M., Kempe, A., & Osbourn, M. (1999). A comparison of serious adverse reactions to whole cell and acellular pertussis vaccines in South Australia [2]. Medical Journal of Australia, 171(6), 331-334.
DOI Scopus15 Europe PMC11
1998 Gold, M., Kemp, A., & Osbourne, M. (1998). (Letter) Counting the cost of disrupting the vaccine cold chain. Medical Journal of Australia, 168(9), 471-472.
1998 Gold, M. S., Kemp, A. E., & Osbourne, M. (1998). Counting the cost of disrupting the vaccine cold chain [4]. Medical Journal of Australia, 168(9), 471-472.
DOI Scopus4 Europe PMC3
1997 Hammond, P., Gold, M., Wigg, N., & Volkmer, R. (1997). Preschool hearing screening: Evaluation of a parental questionnaire. Journal of Paediatrics and Child Health, 33(6), 528-530.
DOI Scopus13 Europe PMC10
1997 Wawryk, A., Mavromatis, C., & Gold, M. (1997). Electronic monitoring of the vaccine cold chain in a metropolitan area. British Medical Journal, 315(7107), 518.
DOI Scopus23 Europe PMC13
1990 Gold, M. S., Hill, I. D., & Bowie, M. D. (1990). Primary peptic ulcer disease in childhood. South African Medical Journal, 77(4), 183-185.
Scopus3 Europe PMC1

Year Citation
2024 Kelso, J. M., & Gold, M. S. (2024). Vaccines, medications and food allergy. In Encyclopedia of Food Allergy (pp. V3-66). Elsevier.
DOI Scopus1
2024 Gold, M., & Balakrishnan, M. (2024). Forensic Approach to Death as an Adverse Event Following Immunization. In J. Payne-James, & R. Byard (Eds.), Encyclopedia of Forensic and Legal Medicine (Vol. 2, pp. V2-767). Elsevier.
DOI
2012 Gold, M. (2012). Atopy. In M. South, & D. Isaacs (Eds.), Practical Paediatrics - Seventh Edition (7 ed., pp. 426-438). United Kingdom: Elsevier.
2007 Gold, M. (2007). The atopic Child. In D. Roberton, & M. South (Eds.), Practical Paediatrics 6th Edition (6 ed., pp. 429-442). UK: Churchill Livingstone.

Year Citation
2023 Loke, P., Wang, X., Lloyd, M., Lozinsky, A. C., Gold, M., O'Sullivan, M., . . . Tang, M. (2023). Two-year post-treatment outcomes following peanut oral immunotherapy. In ALLERGY Vol. 78 (pp. 174-175). GERMANY, Hamburg: WILEY.
2022 Lloyd, M., Loke, P., Ashley, S., Lozinsky, A., Orsini, F., Gold, M., . . . Tang, M. (2022). Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral Immunotherapy. In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Vol. 149 (pp. AB317). MOSBY-ELSEVIER.
2021 Gold, M. S., Quinn, P. J., Campbell, D. E., Peake, J., Smart, J., Robinson, M., . . . Heine, R. G. (2021). Growth, tolerance and safety of an amino acid-based formula supplemented with two human milk oligosaccharides in infants with moderate-to-severe cow's milk protein allergy. In ALLERGY Vol. 76 (pp. 408-409). WILEY.
2017 Gold, M., Omari, T., Abu-Assi, R., Moore, D., Heine, R., Tobin, J. M., . . . Davidson, G. (2017). DIAGNOSTIC MARKERS IN RELATION TO CHALLENGE-PROVEN INFANT COW'S MILK PROTEIN ALLERGY. In INTERNAL MEDICINE JOURNAL Vol. 47 (pp. 15). WILEY.
DOI
2016 Makrides, M., Palmer, D., Sullivan, T., Gold, M., & Prescott, S. (2016). DOES EARLY, REGULAR EGG INTAKE PREVENT EGG ALLERGY IN INFANTS AT HEREDITARY RISK? RESULTS FROM THE STEP RANDOMISED CONTROLLED TRIAL. In EUROPEAN JOURNAL OF PEDIATRICS Vol. 175 (pp. 1438). SPRINGER.
2015 South, C., & Gold, M. (2015). CHALLENGES IN THE DIETARY MANAGEMENT OF A 4 YEAR OLD ENTERALLY FED BOY WITH MULTIPLE IGE MEDIATED ALLERGIES, POOR GROWTH AND A SEVERE FEEDING DISORDER. In INTERNAL MEDICINE JOURNAL Vol. 45 (pp. 20). WILEY-BLACKWELL.
2015 South, C., & Gold, M. (2015). CHALLENGES IN THE DIETARY MANAGEMENT OF A CHILD WITH FOOD PROTEIN INDUCED ENTEROCOLITIS SYNDROME (FPIES), MULTIPLE NON-IgE MEDIATED ALLERGIES, ORAL AVERSION AND FALTERING GROWTH. In INTERNAL MEDICINE JOURNAL Vol. 45 (pp. 19-20). WILEY-BLACKWELL.
2015 Norman, M., Gold, M., South, C., Quinn, P., Chan, D., Palmer, S., & Netting, M. (2015). DOES DIETARY ADVICE IMPROVE THE INGESTION OF NON-ALLERGIC NUTS IN CHILDREN WITH EXISTING NUT ALLERGIES? - A RANDOMISED CONTROLLED TRIAL. In INTERNAL MEDICINE JOURNAL Vol. 45 (pp. 9). WILEY-BLACKWELL.
2007 Gold, M., Kummerow, M., Heddle, R., & Tao, B. (2007). The oral antibiotic challenge test - a useful test to exclude suspected antibiotic allergy. In ALLERGY Vol. 62 (pp. 535). Goteborg, SWEDEN: BLACKWELL PUBLISHING.

Year Citation
2025 Loke, P., Xiaofang, W., Lloyd, M., Ashley, S., Lozinsky, A. C., Rosser, S., . . . Tang, M. L. (2025). Patterns of peanut ingestion in remission vs desensitized patients after completion of peanut oral immunotherapy at 3-years post-treatment. Poster session presented at the meeting of ALLERGY. SCOTLAND, Glasgow: WILEY.
2015 Netting, M., Louise, J., Gold, M., Quinn, P., Penttila, I., & Makrides, M. (2015). WHOLE EGG AND EGG WHITE, BUT NOT OVALBUMIN OR OVOMUCOID SPECIFIC IgE MAY HELP PREDICT BAKED EGG TOLERANCE IN YOUNG EGG ALLERGIC CHILDREN. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
2015 Netting, M., Louise, J., Gold, M., Quinn, P., Penttila, I., & Makrides, M. (2015). SKIN PRICK TESTING TO COMMON EGG ALLERGENS DOES NOT PREDICT BAKED EGG TOLERANCE IN YOUNG EGG ALLERGIC CHILDREN. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
2015 Netting, M., Louise, J., Gold, M., Quinn, P., Penttila, I., & Makrides, M. (2015). EGG ALLERGEN SPECIFIC IgE TO WHOLE EGG IgG4 RATIOS MAY HELP PREDICT BAKED EGG TOLERANCE IN YOUNG EGG ALLERGIC CHILDREN. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
2015 Best, K. P., Sullivan, T., Gold, M., Kennedy, D., Martin, J., Palmer, D., & Makrides, M. (2015). Journal of Peadiatrics and Child Health. Poster session presented at the meeting of PSANZ. Melbourne.
2014 Best, K., Makrides, M., & Gold, M. (2014). Effect of maternal dietary long chain polyunsaturated fatty acid intake during pregnancy on clinical outcomes of allergic disease in the offspring: a systematic review. Poster session presented at the meeting of Abstracts of Australasian Society of Clinical Immunology and Allergy (ASCIA) 25th Annual Conference, as published in Internal Medicine Journal. Melbourne, Victoria: Wiley.
DOI
2014 Netting, M. J., Makrides, M., Gold, M., Quinn, P., & Penttila, I. (2014). Allergenicity of pasteurised whole raw egg powder compared with fresh whole raw egg. Poster session presented at the meeting of Abstracts from the European Academy of Allergy and Clinical Immunology Congress, as published in Allergy. Copenhagen, Denmark: Wiley.
DOI
2014 Metcalfe, J., D'Vaz, N., Makrides, M., Gold, M. S., Quinn, P., Loh, R., . . . Palmer, D. J. (2014). Multiple egg allergens elicit th2 cytokine responses that are associated with the incidence of egg allergy`. Poster session presented at the meeting of Abstracts of Australasian Society of Clinical Immunology and Allergy (ASCIA) 25th Annual Conference, as published in Internal Medicine Journal. Melbourne, Victoria: Wiley.
DOI
2013 Palmer, D. J., Metcalfe, J., Makrides, M., Gold, M. S., Quinn, P., West, C. E., . . . Prescott, S. L. (2013). Early regular egg exposure in infants with eczema: a randomised controlled trial. Poster session presented at the meeting of Abstracts from the European Academy of Allergy and Clinical Immunology and World Allergy Organization World Allergy and Asthma Congress, as published in Allergy. Milan, Italy: Wiley.
DOI
2013 King, J., Gold, M., Quinn, P., & Chan, D. (2013). USE OF ADJUNCTIVE SYSTEMIC CIDOFOVIR THERAPY IN A CHILD WITH SEVERE RECURRENT RESPIRATORY PAPILLOMATOSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
2012 Camfferman, D., Kennedy, J. D., Gold, M., Simpson, C., & Lushington, K. (2012). SLEEP AND NEUROCOGNITIVE FUNCTION IN CHILDREN WITH ECZEMA. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.

Year Citation
2017 Parsons, J., Merlin, T. L., & Gold, M. (2017). Serious adverse effects associated with human papillomavirus vaccine. World Health Organization.
2017 Parsons, J., Merlin, T. L., & Gold, M. (2017). Serious adverse effects associated with smallpox vaccine. World Health Organization.

Date Role Research Topic Program Degree Type Student Load Student Name
2015 - 2019 Co-Supervisor Newborn Screening for Primary Immunodeficiency Diseases Doctor of Philosophy Doctorate Full Time Dr Jovanka King
2012 - 2015 Co-Supervisor The effect of Prenatal Supplementation with Omega 3 Long Chain Poly-unsaturated Fatty Acids (LCPUFA) on Childhood Allergic Disease at Six Years of Age Doctor of Philosophy Doctorate Full Time Dr Karen Best
2011 - 2014 Principal Supervisor Postmarketing Vaccine Safety Passive Surveillance: An exploratory study of parent and healthcare provider reporting of Adverse Events Following Immunisation (AEFI) Doctor of Philosophy Doctorate Full Time Dr Adriana Parrella
2011 - 2015 Co-Supervisor Nutritional strategies for allergy prevention, diagnosis and treatment, with a specific focus on egg allergy Doctor of Philosophy Doctorate Full Time Mrs Merryn Netting
2009 - 2013 Co-Supervisor The Ethical, Legal, and Social Acceptability of Health Data Linkage in the Australian Context: An Investigation of Current Practices, Perceptions, and Public Attitudes Doctor of Philosophy Doctorate Full Time Ms Vicki Xafis
2008 - 2013 Co-Supervisor Postmarketing Vaccine Safety Surveillance Using Data Linkage: The Issue of Consent Doctor of Philosophy Doctorate Full Time Dr Jesia Berry
2004 - 2011 Co-Supervisor Eczema, Sleep and Daytime Functioning in Children Doctor of Philosophy Doctorate Part Time Mr Danny Camfferman
2003 - 2006 Co-Supervisor The Effect of Egg Ingestion on Ovalbumin Concentration in Human Milk Doctor of Philosophy Doctorate Part Time Ms Debra Palmer
1998 - 2002 Co-Supervisor Factors affecting the immunogenicity and protective efficacy of routine childhood immunisations Doctor of Philosophy Doctorate Full Time Dr Christina Boros

Date Institution Department Organisation Type Country
2010 - 2016 World Health Orgainisation - Health services and related -

Connect With Me

External Profiles

Other Links